Clinical Trial Update: Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial comparing neoadjuvant chemotherapy with and without Zometa in locally advanced breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Histologic Type Breast Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Zometa (Zoledronic acid)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Locally Advanced Breast Cancer, Ductal Histologic Type | Phase 2 | Status: COMPLETED